ContraFect Corporation (CFRX) Social Stream



ContraFect Corporation (CFRX): $0.05

0.02 (-27.95%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add CFRX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#189 of 378

in industry

CONTRAFECT CORP (CFRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CFRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-30 4 $23 $6.5 $14.5 $0.241 5916.6%
2022-03-25 4 $23 $9 $15.25 $0.241 6227.8%
2022-04-07 3 $23 $9 $15.25 $0.241 6227.8%
2022-05-26 3 $23 $9 $14 $0.241 5709.13%
2022-06-08 4 $23 $7 $12.6 $0.241 5128.22%
2022-07-14 4 $9 $1 $4.2 $0.241 1642.74%
2022-08-15 3 $9 $1 $5 $0.241 1974.69%
2022-11-22 2 $560 $240 $400 $0.241 165875.1%
2023-04-13 2 $560 $3 $190 $0.241 78738.17%
2023-05-23 2 $7 $3 $5 $0.241 1974.69%
2023-09-21 1 $7 $3 $5 $0.241 1974.69%

The Trend in the Analyst Price Target


Over the past 40 months, CFRX's average price target has gone down $11.33.

CFRX reports an average of 37,944.53% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-22 3 7 1 3.666 0.15 2344%
2022-11-22 2 560 240 400.000 0.15 266566.67%
2022-11-22 3 560 240 400.000 0.15 266566.67%
2022-11-22 2 7 1 3.666 0.15 2344%
2023-06-22 1 7 3 5.000 1.54 224.68%

CFRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


CFRX's average broker recommendation rating improved by 0 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CFRX as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, CONTRAFECT CORP's upside potential (average analyst target price relative to current price) is higher than 1289.36% of them.
  • CONTRAFECT CORP's number of analysts covering the stock is greater than 108.17% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the micro market cap category, CONTRAFECT CORP's variance in analysts' estimates is lower than -1066.59% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, CONTRAFECT CORP's average analyst price target is higher than 366.41% of them.

In the Pharmaceutical Products industry, EDSA, SCYX, and DARE are the three stocks most similar to CONTRAFECT CORP regarding the price target and analyst recommendation information presented here.

What is the outlook for CFRX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!